Manning & Napier Group's TEVA Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 44 shares of Teva Pharmaceutical Industries Limited (TEVA) worth $1,379, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in TEVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 33,713 shares. Largest reduction occurred in Q4 2015, reducing 222,570 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +44 | New Buy | 44 | $31.34 |
| Q3 2018 | -10,191 | Sold Out | 10,191 | $24.24 |
| Q2 2018 | +10,191 | New Buy | 10,191 | $24.24 |
| Q2 2017 | -96,678 | Sold Out | 0 | $0.00 |
| Q1 2017 | +12,645 | Add 15.05% | 96,678 | $32.08 |
| Q4 2016 | -29,403 | Reduce 25.92% | 84,033 | $36.24 |
| Q3 2016 | -2,866 | Reduce 2.46% | 113,436 | $46.00 |
| Q2 2016 | +5,110 | Add 4.60% | 116,302 | $50.22 |
| Q1 2016 | -2,031 | Reduce 1.79% | 111,192 | $53.50 |
| Q4 2015 | -222,570 | Reduce 66.28% | 113,223 | $65.63 |
| Q3 2015 | -720 | Reduce 0.21% | 335,793 | $56.46 |
| Q2 2015 | +25,090 | Add 8.06% | 336,513 | $59.09 |
| Q1 2015 | +18,335 | Add 6.26% | 311,423 | $62.29 |
| Q4 2014 | -86 | Reduce 0.03% | 293,088 | $57.50 |
| Q3 2014 | +28,209 | Add 10.65% | 293,174 | $53.75 |
| Q2 2014 | +33,713 | Add 14.58% | 264,965 | $52.41 |
| Q1 2014 | -237 | Reduce 0.10% | 231,252 | $52.83 |
| Q4 2013 | -23,467 | Reduce 9.20% | 231,489 | $40.08 |
| Q3 2013 | +3,438 | Add 1.37% | 254,956 | $37.77 |
| Q2 2013 | +251,518 | Add 0.00% | 251,518 | $39.19 |
Manning & Napier Group's Teva Pharmaceutical Industries Limited Investment FAQs
Manning & Napier Group first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q2 2013, acquiring 251,518 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held Teva Pharmaceutical Industries Limited (TEVA) for 48 quarters since Q2 2013.
Manning & Napier Group's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q2 2013, adding 251,518 shares worth $9.86 M.
According to the latest 13F filing for Q4 2025, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 44 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $1,379.
As of the Q4 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 0.00% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 336,513 shares, as reported at the end of Q2 2015.